|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.10%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
VTYX
|
Ventyx Biosciences, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
VRNA
|
Verona Pharma plc
|
0.09%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.09%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.09%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
ENTA
|
Enanta Pharmaceuticals, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
CTKB
|
Cytek Biosciences, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
AUPH
|
Aurinia Pharmaceuticals Inc
|
0.09%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.08%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
0.08%
|
US
|
NYSE
|
|
NVAX
|
Novavax, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|